See more : Norcros plc (NXR.L) Income Statement Analysis – Financial Results
Complete financial analysis of China Natural Resources, Inc. (CHNR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Natural Resources, Inc., a leading company in the Waste Management industry within the Industrials sector.
- Amesite Inc. (AMST) Income Statement Analysis – Financial Results
- Medallion Metals Limited (MM8.AX) Income Statement Analysis – Financial Results
- DevMar Equities, Inc. (DEVM) Income Statement Analysis – Financial Results
- Tokyo Century Corporation (TCNRF) Income Statement Analysis – Financial Results
- Naqi Water Company (2282.SR) Income Statement Analysis – Financial Results
China Natural Resources, Inc. (CHNR)
About China Natural Resources, Inc.
China Natural Resources, Inc., through its subsidiaries, engages in the exploration and mining of metal properties in the People's Republic of China. It explores for lead, silver, and other nonferrous metals. The company holds interest in the Moruogu Tong mine that covers an area of 7.81 square kilometers located in Bayannaoer City, Inner Mongolia. It also offers equipment for rural wastewater treatment; and engineering, procurement, and construction services related to wastewater treatment. The company was incorporated in 1993 and is headquartered in Sheung Wan, Hong Kong. China Natural Resources, Inc. is a subsidiary of Feishang Group Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 20.31M | 18.74M | 6.87M | 12.97M | 0.00 | 0.00 | 0.00 | 18.34M | 8.30M | 41.36M | 156.67M | 148.15M | 100.81M | 107.75M | 846.08M | 126.10M | 145.34M | 3.89M | 3.97M | 3.05M | 9.16M | 10.09M | 6.94M | 476.25M | 527.37M | 1.15B | 1.83B | 2.11B |
Cost of Revenue | 0.00 | 14.49M | 18.49M | 6.85M | 12.75M | 0.00 | 0.00 | 0.00 | 31.94M | 6.56M | 25.10M | 104.93M | 95.53M | 58.83M | 95.64M | 790.86M | 38.59M | 36.77M | 3.33M | 3.38M | 2.77M | 8.50M | 9.83M | 6.39M | 467.83M | 510.81M | 1.09B | 1.68B | 0.00 |
Gross Profit | 0.00 | 5.82M | 241.00K | 13.00K | 217.00K | 0.00 | 0.00 | 0.00 | -13.59M | 1.74M | 16.26M | 51.74M | 52.62M | 41.98M | 12.11M | 55.23M | 87.51M | 108.56M | 565.15K | 596.03K | 273.18K | 662.25K | 256.62K | 553.92K | 8.43M | 16.56M | 56.30M | 150.20M | 2.11B |
Gross Profit Ratio | 0.00% | 28.67% | 1.29% | 0.19% | 1.67% | 0.00% | 0.00% | 0.00% | -74.11% | 20.96% | 39.31% | 33.03% | 35.52% | 41.64% | 11.24% | 6.53% | 69.40% | 74.70% | 14.52% | 15.00% | 8.97% | 7.23% | 2.54% | 7.98% | 1.77% | 3.14% | 4.90% | 8.22% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 12.88M | 36.75M | 22.87M | 7.14M | 5.81M | 6.21M | 6.20M | 15.01M | 18.89M | 12.23M | 17.91M | 96.76M | 73.67M | 92.09M | 66.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 700.00K | 922.00K | 2.00K | 2.00K | 0.00 | 0.00 | 23.00K | 31.00K | 80.00K | 124.00K | 3.89M | 3.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 12.88M | 37.45M | 23.79M | 7.14M | 5.82M | 6.21M | 6.20M | 15.04M | 18.93M | 12.31M | 18.03M | 100.65M | 76.95M | 92.09M | 66.59M | 78.71M | 52.55M | 14.17M | 6.73M | 8.02M | 6.40M | 11.16M | 15.22M | 19.40M | 23.86M | 35.60M | 33.12M | 50.62M | 0.00 |
Other Expenses | 0.00 | 904.00K | -183.00K | 1.62M | 0.00 | 0.00 | 0.00 | 15.00K | 32.00K | -169.00K | -167.00K | -762.00K | 1.55M | 9.03M | 0.00 | 0.00 | 0.00 | 0.00 | 258.35K | 248.34K | 190.40K | 836.09K | 14.78M | 3.84M | 1.09M | 1.66M | 1.66M | 1.66M | 0.00 |
Operating Expenses | 12.88M | 37.45M | 23.79M | 7.14M | 5.82M | 6.21M | 6.20M | 18.63M | 18.93M | 12.13M | 19.13M | 105.68M | 78.50M | 101.12M | 66.59M | 78.71M | 52.55M | 14.17M | 6.99M | 8.27M | 6.59M | 11.99M | 30.00M | 23.25M | 24.95M | 37.26M | 34.77M | 52.28M | 0.00 |
Cost & Expenses | 12.88M | 51.93M | 42.29M | 14.00M | 18.57M | 6.21M | 6.20M | 18.63M | 50.87M | 18.70M | 44.24M | 210.60M | 174.03M | 159.95M | 162.22M | 869.57M | 91.14M | 50.94M | 10.32M | 11.65M | 9.36M | 20.50M | 39.83M | 29.64M | 492.78M | 548.06M | 1.13B | 1.73B | 0.00 |
Interest Income | 48.00K | 15.61M | 16.94M | 18.00K | 16.00K | 26.00K | 39.00K | 194.00K | 1.06M | 1.60M | 1.81M | 2.62M | 1.71M | 1.11M | 2.65M | 4.27M | 4.52M | 904.51K | 0.00 | 16.56K | 314.57K | 670.52K | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 4.02M | 4.13M | 38.00K | 60.00K | 0.00 | 14.00K | 174.00K | 1.05M | 1.59M | 360.00K | 43.77M | 32.22M | 6.01M | 2.65M | 1.84M | 0.00 | 0.00 | 209.91K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.92M | 0.00 |
Depreciation & Amortization | 543.00K | 2.53M | 2.76M | 2.38M | 1.25M | 67.00K | 1.81M | 2.97M | 1.83M | 9.12M | 27.50M | 19.06M | 15.39M | 12.89M | 16.03M | 18.29M | 3.56M | 3.15M | 258.35K | 248.34K | 190.40K | 844.36K | 7.51M | 3.84M | 1.09M | 1.66M | 1.66M | 1.66M | 0.00 |
EBITDA | -12.34M | -24.18M | -4.27M | -6.08M | -4.33M | -6.14M | -4.40M | -1.55M | -35.51M | -16.88M | 24.28M | 3.70M | 13.66M | -51.44M | -54.47M | -23.49M | 38.53M | 97.55M | 1.03M | 7.34M | -6.13M | -10.49M | -13.58M | -18.85M | -15.43M | 24.84M | 23.18M | 99.58M | 2.11B |
EBITDA Ratio | 0.00% | -62.19% | -22.79% | -88.50% | -33.40% | 0.00% | 0.00% | 0.00% | -153.39% | 194.33% | -2.97% | -21.16% | -5.92% | -51.03% | -25.04% | 8.07% | 30.96% | 63.73% | 26.56% | 184.79% | 556.79% | 425.65% | -134.62% | -366.43% | -5.41% | 4.71% | -0.65% | 5.13% | 100.00% |
Operating Income | -12.88M | -15.16M | -7.03M | -7.13M | -5.60M | -6.21M | -6.20M | -20.55M | -34.18M | -27.38M | -2.88M | -52.99M | -25.88M | 59.14M | 54.47M | 23.49M | 34.96M | 94.40M | 6.43M | 7.68M | 6.32M | 11.33M | 29.74M | 22.69M | -16.52M | 20.70M | 21.53M | 97.92M | 2.11B |
Operating Income Ratio | 0.00% | -74.65% | -37.52% | -103.82% | -43.17% | 0.00% | 0.00% | 0.00% | -186.32% | -329.71% | -6.95% | -33.82% | -17.47% | 58.66% | 50.55% | 2.78% | 27.73% | 64.95% | 165.15% | 193.33% | 207.34% | 123.67% | 294.75% | 326.79% | -3.47% | 3.92% | 1.87% | 5.36% | 100.00% |
Total Other Income/Expenses | 4.55M | 8.82M | -37.90M | 24.15M | -43.70M | 31.00K | 25.00K | 74.00K | 1.50M | 992.00K | 3.73M | 950.00K | 5.96M | 643.81M | -8.80M | 5.07M | 1.90M | 5.83M | 45.97M | 34.31M | -23.09M | -71.49M | -327.45M | -42.98M | 10.34M | -43.88M | 6.62M | -48.13M | -2.11B |
Income Before Tax | -8.34M | -16.43M | -52.84M | 24.16M | -5.65M | -6.18M | -6.18M | -23.04M | -34.00M | -26.38M | 857.00K | -97.62M | -52.08M | 582.50M | -63.28M | 84.43M | 36.82M | 100.23M | -13.84M | -22.43M | -16.77M | -60.16M | -297.70M | -20.29M | -6.18M | -23.18M | 28.15M | 49.79M | 0.00 |
Income Before Tax Ratio | 0.00% | -80.92% | -282.02% | 351.87% | -43.53% | 0.00% | 0.00% | 0.00% | -185.38% | -317.76% | 2.07% | -62.31% | -35.15% | 577.80% | -58.73% | 9.98% | 29.20% | 68.96% | -355.60% | -564.38% | -550.54% | -656.46% | -2,950.21% | -292.14% | -1.30% | -4.40% | 2.45% | 2.72% | 0.00% |
Income Tax Expense | 0.00 | 5.86M | 2.14M | -1.42M | 60.00K | -42.00K | 23.82M | 4.42M | 1.50M | 6.84M | 2.14M | -16.18M | 14.04M | 12.22M | 2.44M | 8.40M | 12.06M | 15.15M | 32.29K | 8.28K | 25.41M | 49.67K | 1.58M | 2.89M | -9.53M | 32.29M | 9.94M | 14.11M | -20.82M |
Net Income | -12.44M | -22.30M | -54.97M | 24.34M | -5.71M | -6.13M | -30.00M | -23.04M | -35.51M | -43.15M | -335.40M | -89.70M | -65.98M | 574.40M | 54.14M | 76.03M | 24.76M | 72.52M | -13.87M | -22.44M | -31.73M | -60.21M | -30.15M | -23.17M | -6.99M | -52.98M | 18.22M | 35.68M | 20.82M |
Net Income Ratio | 0.00% | -109.80% | -293.41% | 354.39% | -43.99% | 0.00% | 0.00% | 0.00% | -193.58% | -519.67% | -810.94% | -57.26% | -44.53% | 569.76% | 50.25% | 8.99% | 19.64% | 49.90% | -356.43% | -564.79% | -1,041.58% | -657.00% | -298.77% | -333.69% | -1.47% | -10.05% | 1.59% | 1.95% | 0.99% |
EPS | -0.68 | -13.61 | -6.75 | 3.89 | -1.02 | -0.25 | -1.20 | -0.92 | -1.43 | -1.73 | -67.32 | -3.60 | -2.79 | 127.50 | 2.58 | 20.40 | 1.86 | 6.35 | -6.95 | -11.24 | -15.90 | -30.16 | -35.99 | -32.38 | -11.80 | -439.49 | 3.05 | 95.48 | 129.95 |
EPS Diluted | -1.01 | -13.61 | -6.75 | 3.89 | -1.02 | -0.25 | -1.20 | -0.92 | -1.43 | -1.73 | -67.30 | -3.60 | -2.79 | 125.75 | 2.48 | 17.65 | 1.43 | 5.25 | -6.86 | -9.98 | -14.65 | -30.16 | -35.99 | -32.38 | -11.80 | -439.49 | 3.04 | 95.48 | 129.95 |
Weighted Avg Shares Out | 12.27M | 1.64M | 8.14M | 6.26M | 5.58M | 24.91M | 24.91M | 24.91M | 24.91M | 24.91M | 4.98M | 24.91M | 23.61M | 22.44M | 21.00M | 19.28M | 13.29M | 11.40M | 2.00M | 2.00M | 2.00M | 2.00M | 837.78K | 715.66K | 592.93K | 120.56K | 605.26K | 150.00K | 123.08K |
Weighted Avg Shares Out (Dil) | 8.22M | 1.64M | 8.14M | 6.26M | 5.58M | 24.91M | 24.91M | 24.91M | 24.91M | 24.91M | 4.98M | 24.91M | 23.61M | 22.75M | 21.82M | 22.28M | 17.35M | 13.80M | 2.02M | 2.25M | 2.17M | 2.00M | 837.78K | 715.66K | 592.93K | 120.56K | 605.26K | 150.00K | 123.08K |
China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements
CHINA NATURAL RESOURCES REPORTS FULL YEAR 2023 RESULTS
CHINA NATURAL RESOURCES, INC. ANNOUNCES THE CLOSING OF REGISTERED DIRECT PLACEMENT OF $3.27 MILLION OF COMMON SHARES AND PRIVATE PLACEMENT WARRANTS
CHINA NATURAL RESOURCES, INC. ANNOUNCES REGISTERED DIRECT PLACEMENT OF $3.27 MILLION OF COMMON SHARES AND PRIVATE PLACEMENT WARRANTS
Why Is China Natural Resources (CHNR) Stock Up 202% Today?
Why Is China Natural Resources (CHNR) Stock Up 45% Today?
CHINA NATURAL RESOURCES TO SELL PRECISE SPACE-TIME TECHNOLOGY
Stricter standards needed for carbon offsets, congressional reps urge
China Natural Resources Reports Full Year 2020 Results
China Natural Resources Appoints 20-year Pharmaceutical Executive Dr. Peng Wenlie as Vice President
Source: https://incomestatements.info
Category: Stock Reports